Investors - Press Releases
|View printer-friendly version|
Bainbridge Health Partners with Tabula Rasa HealthCare’s subsidiary DoseMe To Expand Medication Management Capabilities to Health System(s)
“Managing medications to prevent patient harm and to reduce waste is an incredibly complex and challenging process for hospital clinicians,” said Joseph Kaupp, Co-founder and CEO of
DoseMeRx is a precision dosing software that was developed specifically for clinical practice. It is a simple, yet powerful tool helping healthcare providers calculate the optimal dose of drugs monitored by therapeutic drug monitoring to streamline operations, reduce adverse drug events, decrease costs, and improve patient outcomes.
"The precision dosing capabilities of DoseMeRx, combined with Bainbridge's platform, will provide new insights into optimizing intravenous medications in the acute care setting,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “By bringing together our technologies, we increase the potential to support healthcare organizations to ensure medications are being appropriately prescribed and delivered to patients in the safest possible manner to improve medication stewardship, reduce adverse drug events and decrease the workload for pharmacy and nursing.”
“We are excited to partner with
DoseMe is a
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on
T: (215) 870-0829
Bob East or Asher Dewhurst
T: (443) 213-0500
Source: Tabula Rasa HealthCare, Inc.